Researchers have found in a new study that Prophylactic use of tamsulosin did not significantly lower the incidence of ...

Britain sleepwalking into a silent epidemic of ketamine addiction, health services "ill-equipped" to cope- users dangerously ...

The Business Research Company's Urinary Retention Therapeutics Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 The Business Research Company's Latest Report ...

Frequent trips to the bathroom can be an early warning sign of an enlarged prostate, also known as Benign Prostatic ...

We have all held in our pee longer than we should, but is it just uncomfortable, or could it actually be harmful to your ...

This important study investigates frequency-dependent effects of transcutaneous tibial nerve stimulation (TTNS) on bladder function in healthy humans and, through a computational model, shows that low ...

The Food and Drug Administration said approved UroGen Pharma’s (URGN) Zusduri for adult patients with recurrent low-grade intermediate-risk non-muscle invasive bladder cancer. The agency pointed out ...

The FDA approved intravesical mitomycin in non–muscle-invasive bladder cancer as an nonsurgical alternative to transurethral ...

Recurrent urinary tract infections and potentially abnormal Pap smears are among the consequences of untreated GSM.

Fortunately a new treatment - or more specifically, a new robotic technology - is offering hope that those men can be treated ...

The FDA has granted approval to UGN-102 for use in patients with low-grade intermediate-risk non-muscle-invasive bladder ...